We are live on ! Find out more
RBOT

Vicarious Surgical

Delisted

RBOT was delisted on the 2nd of March, 2026.

98 hedge funds and large institutions have $264M invested in Vicarious Surgical in 2021 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 11 increasing their positions, 28 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,018% more call options, than puts

Call options by funds: $1.91M | Put options by funds: $171K

214% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 14

40% more funds holding

Funds holding: 7098 (+28)

1% more capital invested

Capital invested by funds: $263M → $264M (+$1.46M)

0.07% more ownership

Funds ownership: 2.63%2.7% (+0.07%)

61% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 28

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
98
Holders Change
+28
Holders Change %
+40%
% of All Funds
1.71%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
44
Increased
11
Reduced
28
Closed
14
Calls
$1.91M
Puts
$171K
Net Calls
+$1.74M
Net Calls Change
+$992K
Name Holding Trade Value Shares
Change
Change in
Stake
PAMP
1
Polar Asset Management Partners
Ontario, Canada
$17.3M
AC
2
Athanor Capital
New York
$14.9M -$1.09M -3,669 -7%
SC
3
Sculptor Capital
New York
$13.5M +$13.4M +45,000 New
Citadel Advisors
4
Citadel Advisors
Florida
$13M +$9.54M +32,044 +277%
Capstone Investment Advisors
5
Capstone Investment Advisors
New York
$12.9M +$2.43M +8,163 +23%
Millennium Management
6
Millennium Management
New York
$12.6M -$880K -2,956 -7%
PC
7
Periscope Capital
Ontario, Canada
$12M -$468K -1,571 -4%
Marshall Wace
8
Marshall Wace
United Kingdom
$11.1M
TAL
9
TIG Advisors LLC
New York
$10.3M +$738K +2,477 +8%
SCM
10
Segantii Capital Management
Hong Kong
$9.99M
6CM
11
683 Capital Management
New York
$9.47M +$9.43M +31,667 New
RCM
12
Ratan Capital Management
Florida
$7.31M
RCM
13
Radcliffe Capital Management
Pennsylvania
$6.6M -$45.6K -153 -0.7%
WAM
14
Weiss Asset Management
Massachusetts
$6.34M +$6.31M +21,190 New
GCL
15
Glazer Capital LLC
New York
$6.09M -$4.94M -16,587 -45%
LP
16
LMR Partners
United Kingdom
$5.07M +$182K +610 +4%
TCA
17
Taconic Capital Advisors
New York
$4.84M -$141K -474 -3%
HSBC Holdings
18
HSBC Holdings
United Kingdom
$4.82M -$2.49M -8,349 -34%
WP
19
Woodline Partners
California
$4.49M +$4.47M +15,000 New
SCM
20
Shaolin Capital Management
Florida
$3.99M +$3.98M +13,354 New
Bank of Montreal
21
Bank of Montreal
Ontario, Canada
$3.8M +$3.77M +12,667 New
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$3.35M +$3.33M +11,188 New
DCM
23
Dupont Capital Management
Delaware
$3.34M -$1.64M -5,500 -33%
Deutsche Bank
24
Deutsche Bank
Germany
$3.31M -$6.24M -20,948 -65%
CM
25
Cohanzick Management
New York
$3.25M +$3.23M +10,849 New

RBOT Hedge Fund Activity: Q2 2021 in Review

98 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q2 2021, worth a combined $264M — up 0.55% from $263M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new RBOT positions and 14 closed out — a net gain of 30 holders — while 11 added to existing stakes and 28 trimmed.

The largest buyer was Sculptor Capital, opening a new position worth an estimated $13.4M. The largest seller was RP Investment Advisors, exiting entirely with an estimated $15.8M sold.

  • 98 institutional investors held Vicarious Surgical (RBOT) as of Q2 2021, up from 70 in Q1 2021.
  • Funds reported $264M of Vicarious Surgical stock for Q2 2021, up 0.55% quarter-over-quarter.
  • 44 funds opened new Vicarious Surgical positions in Q2 2021 and 14 closed out, a net change of +30 holders.
  • The largest Vicarious Surgical buyer in Q2 2021 was Sculptor Capital, an estimated $13.4M added.
  • The largest Vicarious Surgical seller in Q2 2021 was RP Investment Advisors, an estimated $15.8M sold.

Based on aggregated 13F filings for Q2 2021.